-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KSI-501 in Diabetic Macular Edema
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KSI-501 in Diabetic Macular Edema report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. KSI-501 in Diabetic Macular Edema Drug Details: KSI-501 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TT-702 in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TT-702 in Metastatic Castration-Resistant Prostate Cancer (mCRPC) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.TT-702 in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Drug Details:TT-702 is...
-
Product Insights
Nisga Gov – Ksi Lisims LNG Facility – British Columbia
Equip yourself with the essential tools needed to make informed and profitable decisions with our Nisga Gov - Ksi Lisims LNG Facility - British Columbia report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Company Profile
Kodiak Sciences Inc – Company Profile
Kodiak Sciences Inc (Kodiak Sciences) is a clinical-stage biopharmaceutical company that develops therapies for the treatment of chronic and high-prevalence ophthalmic diseases. The company pipeline products includes KSI 301 an anti-VEGF biologic development, which offers wet AMD, diabetic macular edema, retinal vein occlusion and diabetic retinopathy; KSI-501 an anti-IL6 and anti-VEGF bispecific biopolymer conjugate; and KSI-601 a triplet biopolymer conjugate, which treats dry age-related macular degeneration. Kodiak Sciences utilizes proprietary Antibody Biopolymer Conjugate (“ABC”) Platform, that combines biologics design with...
Add to Basket -
Case Studies
Prime Hydration Drink – Success Case Study
Prime is a new sports drink launched by Congo Brands in partnership with celebrities KSI and Logan Paul. The product benefits are marketed towards any type of consumer, not just those engaged in sports or exercise. The beverage's healthy ingredients, exclusivity, and uniqueness contribute to its success, with high demand outpacing product availability. Celebrity endorsement plays a vital role in creating a ready-made target audience. Congo Brands has launched a new sports drink, Prime, in partnership with celebrities KSI and...